NasdaqGS:GFS
NasdaqGS:GFSSemiconductor

Did Elevating Insider Sam Franklin to CFO Just Shift GlobalFoundries' (GFS) AI-Era Strategy Narrative?

GlobalFoundries Inc. has appointed Sam Franklin as Chief Financial Officer, effective December 10, 2025, following his tenure as Senior Vice President of Business Finance & Operations and Interim CFO. Franklin’s promotion consolidates finance, operations, and investor relations under a leader with deep internal experience, potentially reinforcing GlobalFoundries’ long-term execution around differentiated chip technologies and AI-related demand. Now, we’ll explore how Franklin’s elevation to...
TSX:PAAS
TSX:PAASMetals and Mining

Assessing Pan American Silver (TSX:PAAS) Valuation After Exploration Update and New Resource Discoveries

Pan American Silver (TSX:PAAS) just dropped a dense exploration update, and it is exactly the kind of thing resource investors should care about: fresh drill results that can quietly reshape future production. See our latest analysis for Pan American Silver. That backdrop helps explain why, even after a soft 1 day share price return of 1.37 percent, Pan American’s 30 day share price return of 26.61 percent and year to date share price return of 122.11 percent point to powerful, building...
ASX:JBH
ASX:JBHSpecialty Retail

Reassessing JB Hi-Fi (ASX:JBH) Valuation After Major Institutional Exits and Prolonged Share Price Downtrend

Recent filings show major institutions exiting JB Hi-Fi (ASX:JBH), just as the stock slips into a sustained downtrend with clear selling pressure. This combination naturally sharpens investor focus on valuation and risk. See our latest analysis for JB Hi-Fi. That selling has shown up clearly in the tape, with a 90 day share price return of minus 19.22 percent dragging JB Hi Fi to A$91.81. Its five year total shareholder return of 153.35 percent still tells a strong long term story, suggesting...
NasdaqGS:NTRA
NasdaqGS:NTRABiotechs

Natera (NTRA): Assessing Valuation After Strong Multi‑Year Share Price Rally

Natera (NTRA) shares have quietly outpaced much of the biotech space this year, climbing strongly on the back of double digit revenue growth and rapidly improving net income trends that have investors rethinking its valuation. See our latest analysis for Natera. Beyond the latest results, the share price has surged to $231.95, with a roughly 35% 3 month share price return and a 3 year total shareholder return above 430%, which together signal solid, momentum driven optimism around Natera’s...
SEHK:1811
SEHK:1811Renewable Energy

Assessing CGN New Energy (SEHK:1811)’s Valuation After November’s 28% Power Generation Jump

CGN New Energy Holdings (SEHK:1811) just posted a 28% jump in November power generation versus last year, mainly from solar and Korean projects, even though output for the year to date is slightly lower. See our latest analysis for CGN New Energy Holdings. The market seems to be noticing this pickup in operational momentum. The share price is at HK$2.78 and a strong year to date share price return of 18.8 percent supports a robust 5 year total shareholder return of 180 percent, which signals...
NasdaqCM:EXAS
NasdaqCM:EXASBiotechs

Is Exact Sciences (EXAS) Still Undervalued After Its Recent Share Price Surge?

Exact Sciences (EXAS) has quietly become one of the stronger movers in diagnostics this month, with shares climbing sharply as investors focus on its improving revenue growth and narrowing losses in cancer testing. See our latest analysis for Exact Sciences. That sharp 30 day share price return of over 50 percent builds on a powerful 90 day gain and a 67 percent one year total shareholder return. This is a clear sign that sentiment has swung toward Exact Sciences growth story despite its...
NasdaqGS:ELVN
NasdaqGS:ELVNPharmaceuticals

Enliven Therapeutics (ELVN): Taking Stock of Valuation After Leadership Shift and Upcoming ELVN-001 Trial

Enliven Therapeutics (ELVN) just reshuffled its top ranks, naming industry veteran Richard Fair as CEO, President, and board member, while co founder Sam Kintz shifts to Head of Pipeline to focus on R and D. See our latest analysis for Enliven Therapeutics. The leadership shake up lands after a rough stretch for the stock, with a 7 day share price return of minus 22.7 percent and a 1 year total shareholder return of minus 27.17 percent. This suggests momentum has been fading despite the late...
NasdaqGS:SAIC
NasdaqGS:SAICProfessional Services

The Bull Case For Science Applications International (SAIC) Could Change Following Mixed Q3 Results And Capital Return Moves

Science Applications International Corporation recently reported third-quarter fiscal 2026 results showing lower year-on-year sales and earnings, while also updating full-year revenue guidance, completing a US$407.16 million share repurchase program, and declaring a US$0.37 per-share quarterly dividend payable on January 28, 2026. Taken together, the mix of softer quarterly performance, a slightly higher revenue outlook, and ongoing buybacks and dividends points to a company balancing...
CPSE:FLS
CPSE:FLSMachinery

Broker Upgrade On Turnaround Progress Could Be A Game Changer For FLSmidth (CPSE:FLS)

Earlier this week, Danish engineering group FLSmidth was upgraded from "hold" to "buy" by ABG Sundal Collier, with the broker citing expectations of stronger financials, margin expansion and support from higher metal prices as the company exits a major restructuring phase under departing CEO Mikko Keto. The upgrade underscores how FLSmidth’s completed turnaround and exposure to improving metals markets are reshaping expectations for its order pipeline and profitability profile. We’ll now...
NYSE:STAG
NYSE:STAGIndustrial REITs

STAG Industrial (STAG) Valuation Check After Strong Year-to-Date Gains and Recent Pullback

Why STAG Industrial Stock Is Drawing Fresh Attention STAG Industrial (STAG) has quietly outperformed many REIT peers this year, with the stock up around 14% year to date and nearly 10% over the past year, even after a recent pullback. See our latest analysis for STAG Industrial. That steady climb has come even as the latest 1 day and 1 month share price returns are slightly negative, suggesting some profit taking after a strong year to date share price return and solid multi year total...
TSX:CG
TSX:CGMetals and Mining

Is Centerra Gold’s (TSX:CG) Crane Creek Earn-In Sharpening Its North American Growth Strategy?

In December 2025, Headwater Gold Inc. announced a definitive earn-in agreement allowing a Centerra Gold Inc. subsidiary to acquire up to a 70% interest in the fully permitted Crane Creek gold project in Idaho through up to US$25,000,000 in staged exploration expenditures and completion of a preliminary economic assessment. The deal gives Centerra operatorship and a path to majority ownership at Crane Creek, adding another early-stage North American exploration option that could complement...
NasdaqGS:EVCM
NasdaqGS:EVCMSoftware

EverCommerce (EVCM): Revisiting Valuation After AI-Focused Shift, Asset Sales, Acquisitions and Capital Allocation Moves

EverCommerce (EVCM) is back in the spotlight after doubling down on AI powered vertical SaaS, selling noncore assets, buying focused platforms like ZyraTalk, and extending its share buyback plan alongside a fresh debt refinancing. See our latest analysis for EverCommerce. The market seems to be warming back up to that sharper AI powered SaaS focus, with EverCommerce’s 42.96% 1 month share price return pushing the stock near recent highs. However, the 1 year total shareholder return is still...
NYSE:PVH
NYSE:PVHLuxury

PVH’s Profit Squeeze Amid Modest Growth Might Change The Case For Investing In PVH (PVH)

PVH Corp. recently reported third-quarter 2025 results showing sales of US$2,294.3 million but net income dropping sharply to US$4.2 million, with diluted EPS from continuing operations slipping to US$0.09. Despite modest sales growth over the quarter and nine-month period, the steep earnings compression alongside only slightly positive revenue guidance and continued buybacks raises questions about the quality and resilience of PVH’s profit engine. We’ll now examine how PVH’s sharply weaker...
NasdaqGS:DNLI
NasdaqGS:DNLIBiotechs

Assessing Denali Therapeutics (DNLI) Valuation After Its $200 Million Follow-On Equity Offering

Impact of Denali Therapeutics Follow on Offering Denali Therapeutics (DNLI) just wrapped up a $200 million follow on equity offering, mixing new common shares with pre funded warrants. The deal is already shaping how investors think about dilution and Denali’s cash runway. See our latest analysis for Denali Therapeutics. That capital raise comes after a choppy stretch where the share price has swung sharply, with a strong 90 day share price return contrasting with a much weaker one year total...
ASX:BXB
ASX:BXBCommercial Services

Brambles (ASX:BXB): Assessing Valuation as the Share Buyback Signals Confidence and Tightens the Earnings Base

Brambles (ASX:BXB) is back in focus after management ramped up its on market share buyback, steadily retiring shares and signaling confidence in the business while tightening the company’s future earnings per share base. See our latest analysis for Brambles. At A$22.99, Brambles’ share price has eased back over the past quarter even after a strong year to date share price return, while its three year and five year total shareholder returns north of 100% suggest long term momentum is still...
NYSE:DLX
NYSE:DLXCommercial Services

A Fresh Look at Deluxe (DLX) Valuation After Q3 Beat and Credit Rating Upgrade

Third quarter beat and credit upgrade put Deluxe in a stronger spot Deluxe (DLX) just delivered a stronger than expected third quarter and picked up a credit upgrade to B+ with a stable outlook, a one two that signals improving balance sheet strength. See our latest analysis for Deluxe. The upbeat quarter and credit upgrade seem to be feeding into a slow but positive shift in sentiment, with Deluxe’s share price returning 10.29% over the last month and a solid 58.60% three year total...
NYSE:MSA
NYSE:MSACommercial Services

MSA Safety (MSA) Valuation: Is the Market Underpricing Its Steady Growth Story?

MSA Safety (MSA) has quietly outperformed the broader market over the past month, with the stock climbing about 4% even as its one year return remains slightly negative and volatility stays contained. See our latest analysis for MSA Safety. Zooming out, that recent 1 month share price strength sits against a softer backdrop, with the share price still slightly lower year to date while the 3 year total shareholder return of about 30% shows the longer term wealth creation story remains intact...
NasdaqGS:KALU
NasdaqGS:KALUMetals and Mining

Kaiser Aluminum (KALU): Reassessing Valuation After a Strong 3‑Month Share Price Surge

Kaiser Aluminum (KALU) has quietly put together a strong run, with the stock up roughly 19% over the past month and about 40% in the past 3 months, drawing fresh valuation questions. See our latest analysis for Kaiser Aluminum. Zooming out, that recent surge sits on top of a solid year to date, with a share price return of roughly 55% and a three year total shareholder return above 60%. This suggests momentum is still building as investors reassess its recovery story and earnings power. If...
NasdaqGS:PLAB
NasdaqGS:PLABSemiconductor

Photronics (PLAB): Reassessing Valuation After Strong Q4 Earnings Beat and 2026 Growth Guidance

Photronics (PLAB) just turned heads with a fourth quarter that delivered sharp profit growth, even as revenue slipped slightly. The market is paying attention to what that says about margins and demand. See our latest analysis for Photronics. The strong fourth quarter and upbeat 2026 guidance helped propel Photronics’ 1 month share price return to about 72%, contributing to a 5 year total shareholder return of roughly 229%, suggesting momentum is firmly building rather than fading. If this...
NYSE:SNAP
NYSE:SNAPInteractive Media and Services

Does Snap (SNAP) Adding Arlo CEO McRae Hint at a Deeper Product Strategy Shift?

Earlier this month, Snap Inc. expanded its board from eleven to twelve members and appointed Matthew McRae, the long‑time technology executive and current Arlo Technologies CEO, as a director effective December 4, 2025. By adding a leader with deep experience in connected devices, consumer technology, and digital platforms, Snap may be reinforcing its focus on product innovation and operational discipline at the board level. We’ll now consider how bringing Matthew McRae’s technology and...
NasdaqGS:FLYW
NasdaqGS:FLYWDiversified Financial

Assessing Flywire (FLYW) Valuation After New TenPay Global Partnership Expands Asian Education Payments Reach

Flywire (FLYW) just took another deliberate step into Asian education payments by partnering with TenPay Global so Chinese students can use Weixin Pay for tuition at universities in South Korea and Malaysia. See our latest analysis for Flywire. The TenPay Global deal lands at a time when sentiment on Flywire is still cautious, with the share price at $14.77 and a year to date share price return of negative 26.52 percent. However, the 90 day share price return of 10.64 percent and 7 day share...
NasdaqGS:CVBF
NasdaqGS:CVBFBanks

Revisiting CVB Financial’s (CVBF) Valuation After a Year of Underperformance and Recent Share Price Rebound

CVB Financial (CVBF) has quietly drifted lower over the past year even as its underlying business keeps posting steady revenue and profit growth, which naturally raises the question: is the current share price underestimating its earnings power? See our latest analysis for CVB Financial. At around $19.92, the share price has climbed in recent weeks with a 1 month share price return of 5.62 percent. However, the 1 year total shareholder return of negative 9.93 percent shows momentum is still...
NYSE:BLCO
NYSE:BLCOMedical Equipment

Bausch + Lomb (NYSE:BLCO) valuation after analyst upgrades highlight confidence in growth and margin improvement

Bausch + Lomb (NYSE:BLCO) just got a confidence boost, with recent analyst upgrades helping nudge the stock higher even as the company reshapes its balance sheet through a multibillion dollar debt refinancing. See our latest analysis for Bausch + Lomb. The recent analyst upgrades and debt refinancing have helped the share price regain some momentum, with a 30 day share price return of about 9% and a 3 year total shareholder return of roughly 15%, even though year to date share price...